VRSK

Verisk is a textbook high-quality compounder: a subscription-led data-analytics franchise for the insurance industry where ~83% of consolidated revenue is recurring, paid in advance. The economics are exceptional — FY2025 operating margin of 43.7% and net margin of 29.6%, operating cash flow of $1.44B (+25.5% YoY) against just $244M of capex, and the company returns capital aggressively ($624M buybacks, $251M dividends, an additional $1.0B repurchase authorization approved in February 2025). Revenue has grown every year ($2.46B in FY2021 to $3.07B in FY2025, +6.6% YoY), and operating income rose 7.2% — the core engine is intact and durable.

The blemishes are real, though, and they cap the upside. Net income fell 5.2% and diluted EPS slipped 3.4% to $6.48 even as operating income grew, signaling pressure below the line — almost certainly higher interest cost, since long-term debt jumped 54.4% to $4.77B and the current portion of debt nearly tripled to $1.51B. The balance sheet now carries liabilities of $5.89B against just $309M of equity (19x leverage), which makes the headline 293.9% ROE an artifact of a thin, buyback-depleted equity base rather than a sign of safety. The big $2.18B cash build and 45% asset growth suggest a sizeable financing/M&A event in the year; that cash provides a cushion but the near-doubling of current liabilities and the large current debt maturity bear watching.